Selected research
Market Analysis & Forecast
Global Factor XIII Concentrate Market Analysis and Forecast 2026-2032
Market perspective
The global Factor XIII Concentrate market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Factor XIII Concentrate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Europe market for Factor XIII Concentrate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
Read the full market overview
Asia-Pacific market for Factor XIII Concentrate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The China market for Factor XIII Concentrate is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.
The major global manufacturers of Factor XIII Concentrate include CSL Behring. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.
This report presents an overview of global market for Factor XIII Concentrate, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.
This report researches the key producers of Factor XIII Concentrate, also provides the sales of main regions and countries. Of the upcoming market potential for Factor XIII Concentrate, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Factor XIII Concentrate sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Factor XIII Concentrate market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Factor XIII Concentrate sales, projected growth trends, production technology, application and end-user industry.
Factor XIII Concentrate Segment by Company
CSL Behring
Factor XIII Concentrate Segment by Type
1000IU
1600IU
Factor XIII Concentrate Segment by Application
Hospital
Clinic
Factor XIII Concentrate Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Study Objectives
1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Factor XIII Concentrate market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Factor XIII Concentrate and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Factor XIII Concentrate.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Sales (consumption), revenue of Factor XIII Concentrate in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 4: Detailed analysis of Factor XIII Concentrate manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Factor XIII Concentrate sales, revenue, price, gross margin, and recent development, etc.
Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.
Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.
Chapter 10: China type, by application, sales, and revenue for each segment.
Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.
Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.
Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 14: The main concluding insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 1000IU
- 1600IU
Applications
- Hospital
- Clinic
Companies covered
- CSL Behring
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Factor XIII Concentrate Market by Type
- 1.2.1 Global Factor XIII Concentrate Market Size by Type, 2021 VS 2025 VS 2032
- 1.2.2 1000IU
- 1.2.3 1600IU
- 1.3 Factor XIII Concentrate Market by Application
- 1.3.1 Global Factor XIII Concentrate Market Size by Application, 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.4 Assumptions and Limitations
- 1.5 Study Goals and Objectives
2 Factor XIII Concentrate Market Dynamics
- 2.1 Factor XIII Concentrate Industry Trends
- 2.2 Factor XIII Concentrate Industry Drivers
- 2.3 Factor XIII Concentrate Industry Opportunities and Challenges
- 2.4 Factor XIII Concentrate Industry Restraints
3 Global Market Growth Prospects
- 3.1 Global Factor XIII Concentrate Revenue Estimates and Forecasts (2021-2032)
- 3.2 Global Factor XIII Concentrate Revenue by Region
- 3.2.1 Global Factor XIII Concentrate Revenue by Region: 2021 VS 2025 VS 2032
- 3.2.2 Global Factor XIII Concentrate Revenue by Region (2021-2026)
- 3.2.3 Global Factor XIII Concentrate Revenue by Region (2027-2032)
- 3.2.4 Global Factor XIII Concentrate Revenue Market Share by Region (2021-2032)
- 3.3 Global Factor XIII Concentrate Sales Estimates and Forecasts 2021-2032
- 3.4 Global Factor XIII Concentrate Sales by Region
- 3.4.1 Global Factor XIII Concentrate Sales by Region: 2021 VS 2025 VS 2032
- 3.4.2 Global Factor XIII Concentrate Sales by Region (2021-2026)
- 3.4.3 Global Factor XIII Concentrate Sales by Region (2027-2032)
- 3.4.4 Global Factor XIII Concentrate Sales Market Share by Region (2021-2032)
- 3.5 US & Canada & Mexico
- 3.6 Europe
- 3.7 China
- 3.8 Asia (Excluding China)
- 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
- 4.1 Global Factor XIII Concentrate Revenue by Manufacturers
- 4.1.1 Global Factor XIII Concentrate Revenue by Manufacturers (2021-2026)
- 4.1.2 Global Factor XIII Concentrate Revenue Market Share by Manufacturers (2021-2026)
- 4.1.3 Global Factor XIII Concentrate Manufacturers Revenue Share Top 10 and Top 5 in 2025
- 4.2 Global Factor XIII Concentrate Sales by Manufacturers
- 4.2.1 Global Factor XIII Concentrate Sales by Manufacturers (2021-2026)
- 4.2.2 Global Factor XIII Concentrate Sales Market Share by Manufacturers (2021-2026)
- 4.2.3 Global Factor XIII Concentrate Manufacturers Sales Share Top 10 and Top 5 in 2025
- 4.3 Global Factor XIII Concentrate Sales Price by Manufacturers (2021-2026)
- 4.4 Global Factor XIII Concentrate Key Manufacturers Ranking, 2024 VS 2025 VS 2026
- 4.5 Global Factor XIII Concentrate Key Manufacturers Manufacturing Sites & Headquarters
- 4.6 Global Factor XIII Concentrate Manufacturers, Product Type & Application
- 4.7 Global Factor XIII Concentrate Manufacturers' Establishment Date
- 4.8 Market Competitive Analysis
- 4.8.1 Global Factor XIII Concentrate Market CR5 and HHI
- 4.8.2 2025 Factor XIII Concentrate Tier 1, Tier 2, and Tier 3
5 Factor XIII Concentrate Market by Type
- 5.1 Global Factor XIII Concentrate Revenue by Type
- 5.1.1 Global Factor XIII Concentrate Revenue by Type (2021 VS 2025 VS 2032)
- 5.1.2 Global Factor XIII Concentrate Revenue by Type (2021-2032) & (US$ Million)
- 5.1.3 Global Factor XIII Concentrate Revenue Market Share by Type (2021-2032)
- 5.2 Global Factor XIII Concentrate Sales by Type
- 5.2.1 Global Factor XIII Concentrate Sales by Type (2021 VS 2025 VS 2032)
- 5.2.2 Global Factor XIII Concentrate Sales by Type (2021-2032) & (K Units)
- 5.2.3 Global Factor XIII Concentrate Sales Market Share by Type (2021-2032)
- 5.3 Global Factor XIII Concentrate Price by Type
6 Factor XIII Concentrate Market by Application
- 6.1 Global Factor XIII Concentrate Revenue by Application
- 6.1.1 Global Factor XIII Concentrate Revenue by Application (2021 VS 2025 VS 2032)
- 6.1.2 Global Factor XIII Concentrate Revenue by Application (2021-2032) & (US$ Million)
- 6.1.3 Global Factor XIII Concentrate Revenue Market Share by Application (2021-2032)
- 6.2 Global Factor XIII Concentrate Sales by Application
- 6.2.1 Global Factor XIII Concentrate Sales by Application (2021 VS 2025 VS 2032)
- 6.2.2 Global Factor XIII Concentrate Sales by Application (2021-2032) & (K Units)
- 6.2.3 Global Factor XIII Concentrate Sales Market Share by Application (2021-2032)
- 6.3 Global Factor XIII Concentrate Price by Application
7 Company Profiles
- 7.1 CSL Behring
- 7.1.1 CSL Behring Company Information
- 7.1.2 CSL Behring Business Overview
- 7.1.3 CSL Behring Factor XIII Concentrate Sales, Revenue, Price and Gross Margin (2021-2026)
- 7.1.4 CSL Behring Factor XIII Concentrate Product Portfolio
- 7.1.5 CSL Behring Recent Developments
8 North America
- 8.1 North America Factor XIII Concentrate Market Size by Type
- 8.1.1 North America Factor XIII Concentrate Revenue by Type (2021-2032)
- 8.1.2 North America Factor XIII Concentrate Sales by Type (2021-2032)
- 8.1.3 North America Factor XIII Concentrate Price by Type (2021-2032)
- 8.2 North America Factor XIII Concentrate Market Size by Application
- 8.2.1 North America Factor XIII Concentrate Revenue by Application (2021-2032)
- 8.2.2 North America Factor XIII Concentrate Sales by Application (2021-2032)
- 8.2.3 North America Factor XIII Concentrate Price by Application (2021-2032)
- 8.3 North America Factor XIII Concentrate Market Size by Country
- 8.3.1 North America Factor XIII Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 8.3.2 North America Factor XIII Concentrate Sales by Country (2021 VS 2025 VS 2032)
- 8.3.3 North America Factor XIII Concentrate Price by Country (2021-2032)
- 8.3.4 United States
- 8.3.5 Canada
9 Europe
- 9.1 Europe Factor XIII Concentrate Market Size by Type
- 9.1.1 Europe Factor XIII Concentrate Revenue by Type (2021-2032)
- 9.1.2 Europe Factor XIII Concentrate Sales by Type (2021-2032)
- 9.1.3 Europe Factor XIII Concentrate Price by Type (2021-2032)
- 9.2 Europe Factor XIII Concentrate Market Size by Application
- 9.2.1 Europe Factor XIII Concentrate Revenue by Application (2021-2032)
- 9.2.2 Europe Factor XIII Concentrate Sales by Application (2021-2032)
- 9.2.3 Europe Factor XIII Concentrate Price by Application (2021-2032)
- 9.3 Europe Factor XIII Concentrate Market Size by Country
- 9.3.1 Europe Factor XIII Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 9.3.2 Europe Factor XIII Concentrate Sales by Country (2021 VS 2025 VS 2032)
- 9.3.3 Europe Factor XIII Concentrate Price by Country (2021-2032)
- 9.3.4 Germany
- 9.3.5 France
- 9.3.6 U.K.
- 9.3.7 Italy
- 9.3.8 Netherlands
10 China
- 10.1 China Factor XIII Concentrate Market Size by Type
- 10.1.1 China Factor XIII Concentrate Revenue by Type (2021-2032)
- 10.1.2 China Factor XIII Concentrate Sales by Type (2021-2032)
- 10.1.3 China Factor XIII Concentrate Price by Type (2021-2032)
- 10.2 China Factor XIII Concentrate Market Size by Application
- 10.2.1 China Factor XIII Concentrate Revenue by Application (2021-2032)
- 10.2.2 China Factor XIII Concentrate Sales by Application (2021-2032)
- 10.2.3 China Factor XIII Concentrate Price by Application (2021-2032)
11 Asia (Excluding China)
- 11.1 Asia Factor XIII Concentrate Market Size by Type
- 11.1.1 Asia Factor XIII Concentrate Revenue by Type (2021-2032)
- 11.1.2 Asia Factor XIII Concentrate Sales by Type (2021-2032)
- 11.1.3 Asia Factor XIII Concentrate Price by Type (2021-2032)
- 11.2 Asia Factor XIII Concentrate Market Size by Application
- 11.2.1 Asia Factor XIII Concentrate Revenue by Application (2021-2032)
- 11.2.2 Asia Factor XIII Concentrate Sales by Application (2021-2032)
- 11.2.3 Asia Factor XIII Concentrate Price by Application (2021-2032)
- 11.3 Asia Factor XIII Concentrate Market Size by Country
- 11.3.1 Asia Factor XIII Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 11.3.2 Asia Factor XIII Concentrate Sales by Country (2021 VS 2025 VS 2032)
- 11.3.3 Asia Factor XIII Concentrate Price by Country (2021-2032)
- 11.3.4 Japan
- 11.3.5 South Korea
- 11.3.6 India
- 11.3.7 Australia
- 11.3.8 Taiwan
- 11.3.9 Southeast Asia
12 South America, Middle East and Africa
- 12.1 SAMEA Factor XIII Concentrate Market Size by Type
- 12.1.1 SAMEA Factor XIII Concentrate Revenue by Type (2021-2032)
- 12.1.2 SAMEA Factor XIII Concentrate Sales by Type (2021-2032)
- 12.1.3 SAMEA Factor XIII Concentrate Price by Type (2021-2032)
- 12.2 SAMEA Factor XIII Concentrate Market Size by Application
- 12.2.1 SAMEA Factor XIII Concentrate Revenue by Application (2021-2032)
- 12.2.2 SAMEA Factor XIII Concentrate Sales by Application (2021-2032)
- 12.2.3 SAMEA Factor XIII Concentrate Price by Application (2021-2032)
- 12.3 SAMEA Factor XIII Concentrate Market Size by Country
- 12.3.1 SAMEA Factor XIII Concentrate Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
- 12.3.2 SAMEA Factor XIII Concentrate Sales by Country (2021 VS 2025 VS 2032)
- 12.3.3 SAMEA Factor XIII Concentrate Price by Country (2021-2032)
- 12.3.4 Brazil
- 12.3.5 Argentina
- 12.3.6 Chile
- 12.3.7 Colombia
- 12.3.8 Peru
- 12.3.9 Saudi Arabia
- 12.3.10 Israel
- 12.3.11 UAE
- 12.3.12 Turkey
- 12.3.13 Iran
- 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
- 13.1 Factor XIII Concentrate Value Chain Analysis
- 13.1.1 Factor XIII Concentrate Key Raw Materials
- 13.1.2 Raw Materials Key Suppliers
- 13.1.3 Manufacturing Cost Structure
- 13.1.4 Factor XIII Concentrate Production Mode & Process
- 13.2 Factor XIII Concentrate Sales Channels Analysis
- 13.2.1 Direct Comparison with Distribution Share
- 13.2.2 Factor XIII Concentrate Distributors
- 13.2.3 Factor XIII Concentrate Customers
14 Concluding Insights
15 Appendix
- 15.1 Reasons for Doing This Study
- 15.2 Research Methodology
- 15.3 Research Process
- 15.4 Authors List of This Report
- 15.5 Data Source
- 15.5.1 Secondary Sources
- 15.5.2 Primary Sources
- 15.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst